首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Induction of Positive Cellular and Humoral Immune Responses by a Prime-Boost Vaccine Encoded with Simian Immunodeficiency Virus gag/pol.
【24h】

Induction of Positive Cellular and Humoral Immune Responses by a Prime-Boost Vaccine Encoded with Simian Immunodeficiency Virus gag/pol.

机译:用猿猴免疫缺陷病毒gag / pol编码的初免-加强疫苗诱导的阳性细胞和体液免疫反应。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

It is believed likely that immune responses are responsible for controlling viral load and infection. In this study, when macaques were primed with plasmid DNA encoding SIV gag and pol genes (SIVgag/pol DNA) and then boosted with replication-deficient vaccinia virus DIs recombinant expressing the same genes (rDIsSIVgag/pol), this prime-boost regimen generated higher levels of Gag-specific CD4(+) and CD8(+) T cell responses than did either SIVgag/pol DNA or rDIsSIVgag/pol alone. When the macaques were i.v. challenged with pathogenic simian/HIV, the prime-boost group maintained high CD4(+) T cell counts and reduced plasma viral loads up to 30 wk after viral challenge, whereas the rDIsSIVgag/pol group showed only a partial attenuation of the viral infection, and the group immunized with SIVgag/pol DNA alone showed none at all. The protection levels were better correlated with the levels of virus-specific T cell responses than the levels of neutralization Ab responses. These results demonstrate that a vaccine regimen that primes with DNA and then boosts with a replication-defective vaccinia virus DIs generates anti-SIV immunity, suggesting that it will be a promising vaccine regimen for HIV-1 vaccine development.
机译:相信免疫反应可能负责控制病毒载量和感染。在这项研究中,当猕猴用编码SIV gag和pol基因的质粒DNA(SIVgag / pol DNA)引发,然后用表达相同基因的复制缺陷型痘苗病毒DIs重组(rDIsSIVgag / pol)加强时,产生了这种加强免疫的方案与单独的SIVgag / pol DNA或rDIsSIVgag / pol相比,更高的Gag特异性CD4(+)和CD8(+)T细胞应答水平。猕猴是i.v.在受到致病性猿猴/ HIV攻击后,初免-升压组在病毒攻击后维持高达30周的最高CD4(+)T细胞计数并降低血浆病毒载量,而rDIsSIVgag / pol组仅显示病毒感染的部分减弱,而仅用SIVgag / pol DNA免疫的组则完全没有。与中和抗体应答的水平相比,保护水平与病毒特异性T细胞应答的水平更好地相关。这些结果表明,以DNA引发,然后以复制缺陷型痘苗病毒DI加强免疫的疫苗方案可产生抗SIV免疫力,这表明它将是开发HIV-1疫苗的有前途的疫苗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号